Literature DB >> 28815668

Primary low-grade neuroendocrine carcinoma of the skin: An exceedingly rare entity.

Tiffany Y Chen1, Annie O Morrison2, Joe Susa3, Clay J Cockerell3.   

Abstract

Low-grade neuroendocrine tumors (NETs), also known as carcinoid tumor, commonly arise from the gastrointestinal (GI) and pulmonary tracts, but rarely occur in the skin. Cutaneous NET typically occurs as metastases or high-grade primary lesions, called Merkel cell carcinoma. In the few cases described in literature, primary low-grade neuroendocrine carcinomas of the skin (LGNECS) are usually indolent cutaneous nodules, presenting on the head and trunk of elderly patients. LGNECS tumors are histologically similar to its counterparts arising in other anatomic locations. As there is no NET cut-off for the skin due to their rarity, the GI scale was used instead; low-grade NETs have a Ki-67 proliferative index of less than 3%. The distinction between primary and metastatic NET, however, is not absolute and can be difficult. A primary vs metastatic NET diagnosis relies on clinical exclusion of a NET in other, more common, anatomic locations. Here, we present a case of an LGNECS on the scalp of a 72-year-old female patient. Whole body imaging failed to identify any octreotide-avid lesions elsewhere in the patient, aside from 2 positive cervical lymph nodes, which were confirmed with a node dissection and histologic evaluation. This is the 19th reported case of LGNECS and the 2nd reported case of LGNECS with nodal metastasis.
© 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  cutaneous carcinoid; low-grade neuroendocrine carcinomas of the skin; metastasis; neuroendocrine skin; primary cutaneous neuroendocrine

Mesh:

Year:  2017        PMID: 28815668     DOI: 10.1111/cup.13028

Source DB:  PubMed          Journal:  J Cutan Pathol        ISSN: 0303-6987            Impact factor:   1.587


  1 in total

1.  Sweat-gland carcinoma with neuroendocrine differentiation (SCAND): a clinicopathologic study of 13 cases with genetic analysis.

Authors:  Keisuke Goto; Yoji Kukita; Keiichiro Honma; Nobuyuki Ohike; Takaya Komori; Yoshihiro Ishida; Misawo Ishikawa; Takashi Nakatsuka; Soichi Fumita; Koichi Nakagawa; Aya Okabayashi; Yoshifumi Iwahashi; Tomoyuki Tanino; Keisuke Kikuchi; Yoshie Kawahara; Tsunekazu Hishima; Jiro Uehara; Takuma Oishi; Taiki Isei
Journal:  Mod Pathol       Date:  2021-09-12       Impact factor: 7.842

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.